Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 Dec;30(6):927–932. doi: 10.1128/aac.30.6.927

Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis.

L B Heifets, M D Iseman, P J Lindholm-Levy
PMCID: PMC180621  PMID: 3101588

Abstract

We determined the MICs of ethambutol for both Mycobacterium avium and Mycobacterium tuberculosis strains by using broth dilution (7H12 broth, radiometric method) and agar dilution (7H11 agar) methods. We found the MICs to be much lower in liquid than in solid medium. The broth-determined MICs for susceptible M. tuberculosis and most of the M. avium strains were comparable to the levels in blood of patients, being lower than the peak levels. We propose that the MICs, determined radiometrically in in 7H12 broth, be considered as tentative criteria for susceptibility testing of M. avium isolates in future clinical trials. The use of these values instead of critical concentrations should also be considered as an alternative to the conventional susceptibility testing method in chemotherapy of tuberculosis. Ethambutol produced bactericidal effects against both M. tuberculosis and M. avium, and the MIC/MBC ratios were in the same range for both species when MICs and MBCs were tested in 7H12 broth by conventional sampling and plating.

Full text

PDF
927

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bobrowitz I. D. Comparison of ethambutol-INH versus INH-PAS in original treatment of pulmonary tuberculosis. Ann N Y Acad Sci. 1966 Apr 20;135(2):921–939. doi: 10.1111/j.1749-6632.1966.tb45534.x. [DOI] [PubMed] [Google Scholar]
  2. Bobrowitz I. D., Robins D. E. Ethambutol-isoniazid versus PAS-isoniazid in original treatment of pulmonary tuberculosis. Am Rev Respir Dis. 1967 Sep;96(3):428–438. doi: 10.1164/arrd.1967.96.3.428. [DOI] [PubMed] [Google Scholar]
  3. Canetti G., Fox W., Khomenko A., Mahler H. T., Menon N. K., Mitchison D. A., Rist N., Smelev N. A. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ. 1969;41(1):21–43. [PMC free article] [PubMed] [Google Scholar]
  4. Davidson P. T., Khanijo V., Goble M., Moulding T. S. Treatment of disease due to Mycobacterium intracellulare. Rev Infect Dis. 1981 Sep-Oct;3(5):1052–1059. doi: 10.1093/clinids/3.5.1052. [DOI] [PubMed] [Google Scholar]
  5. Dickinson J. M., Aber V. R., Mitchison D. A. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis. Am Rev Respir Dis. 1977 Oct;116(4):627–635. doi: 10.1164/arrd.1977.116.4.627. [DOI] [PubMed] [Google Scholar]
  6. Donomae I., Yamamoto K. Clinical evaluation of ethambutol in pulmonary tuberculosis. Ann N Y Acad Sci. 1966 Apr 20;135(2):849–881. doi: 10.1111/j.1749-6632.1966.tb45528.x. [DOI] [PubMed] [Google Scholar]
  7. Dutt A. K., Stead W. W. Long-term results of medical treatment in Mycobacterium intracellulare infection. Am J Med. 1979 Sep;67(3):449–453. doi: 10.1016/0002-9343(79)90792-7. [DOI] [PubMed] [Google Scholar]
  8. Evans C., Thong K. L. A clinical trial of ethambutol plus capreomycin in the treatment of atypical tuberculosis. Med J Aust. 1969 Oct 11;2(15):744–748. doi: 10.5694/j.1326-5377.1969.tb107379.x. [DOI] [PubMed] [Google Scholar]
  9. Forbes M., Peets E. A., Kuck N. A. Effect of ethambutol on Mycobacteria. Ann N Y Acad Sci. 1966 Apr 20;135(2):726–731. doi: 10.1111/j.1749-6632.1966.tb45518.x. [DOI] [PubMed] [Google Scholar]
  10. Gangadharam P. R., Gonzales E. R. Influence of the medium on the in vitro susceptibility of Mycobacterium tuberculosis to ethambutol. Am Rev Respir Dis. 1970 Oct;102(4):653–655. doi: 10.1164/arrd.1970.102.4.653. [DOI] [PubMed] [Google Scholar]
  11. Heifets L. B., Iseman M. D., Cook J. L., Lindholm-Levy P. J., Drupa I. Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methods. Antimicrob Agents Chemother. 1985 Jan;27(1):11–15. doi: 10.1128/aac.27.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Heifets L. B., Iseman M. D., Lindholm-Levy P. J., Kanes W. Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods. Antimicrob Agents Chemother. 1985 Oct;28(4):570–575. doi: 10.1128/aac.28.4.570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hobby G. L., Lenert T. F. Observations on the action of rifampin and ethambutol alone and in combination with other antituberculous drugs. Am Rev Respir Dis. 1972 Feb;105(2):292–295. doi: 10.1164/arrd.1972.105.2.292. [DOI] [PubMed] [Google Scholar]
  14. KUCK N. A., PEETS E. A., FORBES M. Mode of action of ethambutol on Mycobacterium tuberculosis, strain H37R V. Am Rev Respir Dis. 1963 Jun;87:905–906. doi: 10.1164/arrd.1963.87.6.905. [DOI] [PubMed] [Google Scholar]
  15. Middlebrook G., Reggiardo Z., Tigertt W. D. Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media. Am Rev Respir Dis. 1977 Jun;115(6):1066–1069. doi: 10.1164/arrd.1977.115.6.1066. [DOI] [PubMed] [Google Scholar]
  16. Place V. A., Peets E. A., Buyske D. A., Little R. R. Metabolic and special studies of ethambutol in normal volunteers and tuberculous patients. Ann N Y Acad Sci. 1966 Apr 20;135(2):775–795. doi: 10.1111/j.1749-6632.1966.tb45522.x. [DOI] [PubMed] [Google Scholar]
  17. Schmidt L. H. Studies on the antituberculous activity of ethambutol in monkeys. Ann N Y Acad Sci. 1966 Apr 20;135(2):747–758. doi: 10.1111/j.1749-6632.1966.tb45520.x. [DOI] [PubMed] [Google Scholar]
  18. Snider D. E., Jr, Good R. C., Kilburn J. O., Laskowski L. F., Jr, Lusk R. H., Marr J. J., Reggiardo Z., Middlebrook G. Rapid drug-susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):402–406. doi: 10.1164/arrd.1981.123.4.402. [DOI] [PubMed] [Google Scholar]
  19. THOMAS J. P., BAUGHN C. O., WILKINSON R. G., SHEPHERD R. G. A new synthetic compound with antituberculous activity in mice: ethambutol (dextro-2,2'-(ethylenediimino)-di-l-butanol). Am Rev Respir Dis. 1961 Jun;83:891–893. doi: 10.1164/arrd.1961.83.6.891. [DOI] [PubMed] [Google Scholar]
  20. Tarrand J. J., Gröschel D. H. Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis. J Clin Microbiol. 1985 Jun;21(6):941–946. doi: 10.1128/jcm.21.6.941-946.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Taylor P. C., Schoenknecht F. D., Sherris J. C., Linner E. C. Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors. Antimicrob Agents Chemother. 1983 Jan;23(1):142–150. doi: 10.1128/aac.23.1.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tsukamura M. In vitro antituberculosis activity of a new antibacterial substance ofloxacin (DL8280). Am Rev Respir Dis. 1985 Mar;131(3):348–351. doi: 10.1164/arrd.1985.131.3.348. [DOI] [PubMed] [Google Scholar]
  23. Watson B. M., Smyth J. T. B663 and ethambutol in the treatment of Battey disease. Med J Aust. 1968 Feb 17;1(7):261–263. doi: 10.5694/j.1326-5377.1968.tb82655.x. [DOI] [PubMed] [Google Scholar]
  24. Wolinsky E., Gomez F., Zimpfer F. Sporotrichoid Mycobacterium marinum infection treated with rifampin-ethambutol. Am Rev Respir Dis. 1972 Jun;105(6):964–967. doi: 10.1164/arrd.1972.105.6.964. [DOI] [PubMed] [Google Scholar]
  25. Youmans A. S., Youmans G. P. The Effect of "Tween 80" in Vitro on the Bacteriostatic Activity of Twenty Compounds for Mycobacterium tuberculosis. J Bacteriol. 1948 Aug;56(2):245–252. [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES